Topics

Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO

08:19 EDT 30 Apr 2019 | Xconomy

Do Wall Street investors believe that exosomes, the tiny bubbles once thought to be just cellular garbage bins, may be the key to treating a slew of potential diseases? The coming IPO for Codiak Biosciences will present a test case. Codiak, a Cambridge, MA, company run by former Biogen (NASDAQ: BIIB) research chief Doug Williams, […]

Original Article: Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO

NEXT ARTICLE

More From BioPortfolio on "Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO"

Quick Search